CVS Group (OTCMKTS:CVSGF – Get Free Report) is expected to issue its resultson Thursday, September 24th. Analysts expect the company to post earnings of $0.6150 per share and revenue of $478.0470 million for the quarter.
CVS Group Price Performance
Shares of CVS Group stock opened at $16.60 on Wednesday. The business’s 50 day simple moving average is $16.62 and its 200 day simple moving average is $16.52. CVS Group has a 52-week low of $14.50 and a 52-week high of $17.66.
Analyst Upgrades and Downgrades
Separately, Barclays raised shares of CVS Group to an “overweight” rating in a research note on Friday, July 31st. Two investment analysts have rated the stock with a Buy rating, According to data from MarketBeat, the stock currently has a consensus rating of “Buy”.
About CVS Group
CVS Group PLC operates as a leading provider of veterinary and pet care services in the United Kingdom, offering a comprehensive range of clinical and diagnostic solutions for companion and farm animals. Through its network of practices, the company delivers routine veterinary care, advanced surgical procedures, dental services and pet wellness programs. Its integrated model seeks to streamline care delivery by combining in‐house clinical teams with centralized support functions.
In addition to traditional veterinary services, CVS Group maintains a dedicated specialist business that includes emergency and referral practices, as well as mobile clinical units.
Recommended Stories
- Five stocks we like better than CVS Group
- Meta’s Muse Highlights Arm’s Growing Role in AI Infrastructure
- Oura’s $15.6 Billion IPO Is Betting Investors See More Than a Smart Ring
- AMD Chips Away at NVIDIA’s AI Throne
- Is the Fed Playing Chess With Rates—Or Just Behind the Curve Again?
Receive News & Ratings for CVS Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Group and related companies with MarketBeat.com's FREE daily email newsletter.
